Atwood & Palmer Inc Gamida Cell Ltd. Transaction History

Atwood & Palmer Inc

  • $1.43 Billion
  • Q4 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 20, 2020
BUY
$2.9 - $4.76 $2,900 - $4,760
1,000 New
1,000 $3,000

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Atwood & Palmer Inc Portfolio

Follow Atwood & Palmer Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email